Abstract
Superselective intraophthalmic artery chemotherapy (SSIOAC) has come to the forefront in the treatment of retinoblastoma. We have presented the histopathologic and radiologic findings of a retinoblastoma patient who subsequently developed enophthalmos, choroidal ischemia, iris atrophy, and scleritis as delayed toxicities of SSIOAC.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Transactions - American Academy of Ophthalmology and Otolaryngology
Paper Title
Journal
Date
